Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon
Thumbnail

Could 2020 be a year without HIMSS?

Despite international travel interruptions due to COVID-19, HIMSS20 is moving “full steam ahead as scheduled” for March 9 to 13 in Orlando.

Thumbnail

AI could save the vision of newborns

AI technology could play a vital rule in the diagnosis and treatment of aggressive posterior retinopathy of prematurity (AP-ROP) in infants, according to new research published in Ophthalmology.

SymphonyAI Group acquires TeraRecon

SymphonyAI Group, a private group of companies specializing in AI, announced Wednesday, March 4, that it has acquired TeraRecon. No financial details have been shared at this time.

4 key ways augmented reality could make an impact on interventional radiology

Augmented reality (AR) technology could play a pivotal role in the interventional radiology (IR) suite of the future, according to a new study published in the Journal of Vascular and Interventional Radiology.

Thumbnail

New collaboration focused on using AI to improve the speed, accuracy of cancer care

Proscia, a Philadelphia-based AI technology company, has partnered with the University of California, San Francisco (UCSF) to improve cancer diagnoses and patient outcomes.

Thumbnail

AI boosts quality of breast cancer screenings when paired with human radiologists

AI algorithms can improve the overall quality of breast cancer screenings, according to a new study published in JAMA Network Open.

Thumbnail

TeraRecon awarded 2 AI patents for medical imaging technology

TeraRecon announced Monday, March 2, that its AI solutions have been awarded two technology patents from the U.S. Patent and Trademark Office.

Thumbnail

3 things radiologists need to realize AI’s full potential

AI is expected to impact radiology more than perhaps any other medical specialty. In healthcare, though, nothing is a given.

Displaying 361 - 368 of 3584

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup